Dr Nigel Gericke has been researching the ethnobotany, chemistry and pharmacology of Sceletium since 1991. He was joined by Deon Hofmeyr in 2002, and they were joined by Halls Investments in 2006 to form HG&H Pharmaceuticals (Pty) Ltd.
HG&H Pharmaceuticals implements a rigorous evidence-based approach to scientifically and medically validate the safety, efficacy and quality of Zembrin®, our proprietary extract of Sceletium tortuosum.
HG&H works closely with an international medical and scientific collaborative team.
Dr Nigel Gericke Nigel is a founding Director of HG&H Pharmaceuticals (Pty) Ltd. He is a South African medical doctor, botanist , ethnopharmacologist and entrepreneur. He is a current member of the medicinal plants specialist group of the Species Survival Commission of IUCN. Previous positions include head of ethnobotany, Esperanza Medicines Foundation, and founding director of Phyto Nova (Pty) Ltd. … Read more
Deon Hofmeyr Deon is a founding Director of HG&H, and an entrepreneur investing in private equity and venture capital businesses in South Africa. Previous positions include Managing Director of The Office Plant (Pty) Ltd and Real Landscapes (Pty) Ltd, Managing Director of the Soft Services Division of Servest Ltd. Deon has a BSc Agriculture (Horticulture) degree, and was employed as a consultant for the South African Citrus Exchange. … Read more
Peter Backwell Pete is a Director of HG&H, a Director of H L Hall and Sons Holdings Limited, and Managing Director of H L Hall and Sons Investments (Pty) Ltd. Pete qualified as a Chartered Accountant at Deloitte and was a partner in the Tax Division, specialising in corporate income tax. He joined the Nedcor Group in 1991, working initially in the tax department before moving to the banking side of the business in 1994. Pete later headed up Nedbank’s Corporate Banking Division before his … Read more
Dr Rob Snaddon Rob is a Director of HG&H, a Director of H L Hall and Sons Holdings Limited, and Managing Director of H L Hall and Sons Limited. Rob obtained BSc Engineering degree at Wits University in 1973. He continued his post-graduate studies at the University of Bristol and earned his PhD in 1979. Later that year he joined General Electric Corporate R&D (GE) in New York and was involved in research and development. He moved with GE to Pennsylvania in 1986 to take … Read more
Richard Franklin Richard completed his BSc (Hons) Computer Science degree in 1997, and started his working career at the Sasol Synfuels facility in Secunda, focusing plant optimization and management information systems. He completed his MBA on part-time basis in 2002. The following year Richard joined McKinsey & Co as a management consultant, getting exposure to the local and international business environment through various strategic projects while based in South Africa, Nigeria, India, Singapore and Australia. Richard joined Halls Investments in September 2008, and is responsible … Read more
Dr Vladimir Badmaev Vladimir Badmaev MD, PhD (clinical anatomical pathology/immunopharmacology) is the author and coauthor of over 70 scientific and popular scientific articles, thirteen books, over 20 US and International patents (three awarded Thomas Alva Edison Award) and 9 successful IND applications with the FDA. The lifelong goal of Dr. Badmaev is to establish Indo-Tibetan medicine as a permanent element in the health care education and health care system in the West. Joined PLThomas Inc. and PoliNat Inc. since October 2009 as a Director of … Read more
Dr John Endres John is a Naturopathic Physician and licensed as a primary care physician in Washington State. He is the Chief Scientific Officer for AIBMR Life Sciences, where he manages a team of scientists, who collectively and collaboratively provide independent contract scientific research; strategic partnership development; foreign and domestic regulatory guidance services; safety assessments; toxicological studies; in vitro, animal, and human clinical trials; and product development solutions to the natural products, functional foods and beverage industries. AIBMR Life Sciences works with natural products and … Read more
Dr Rudolf Giger Since retiring from from Novartis Pharma AG, Rudolf has been offering consulting services as CEO of Giger MedChem Consulting, with expertise in medicinal chemistry, organic chemistry, synthetic chemistry, natural product chemistry, chemistry of drug metabolism and combinatorial chemistry. He is currently head of medicinal chemistry for Esperanza Medicines Foundation. He has a Ph.D. in organic chemistry from the Swiss Federal Institute of Technology, Zurich, and a post-doctorate at California Institute of Technology, Pasadena (CALTECH). His professional career in the pharmaceutical industry spans … Read more
Professor Alan Harvey Professor Alan Harvey has a PhD in Pharmacology from the University of Strathclyde, and an MBA from the Open University. He is a fellow of Institute of Biology (FIBiol), C. Biol. He is a founding Director of the Strathclyde Institute for Drug Research (SIDR), and has been Director for twenty two years. This is a self-funding organisation of Strathclyde University that develops commercially relevant drug research and facilitates interactions with industry worldwide. Alan has been responsible for all aspects of SIDR’s activities: … Read more
Professor Diana Alicia Jerusalinsky Dr. in Biological Sciences, PhD of the University of Buenos Aires (1987). Head Professor of General Biology and Cell Biology, Dept. Biological and Health Sciences (VI), Common Basic Cycle, UBA (2004-2011) (Formerly, Associated Prof. since 1993). Director Lab. of Neuroplasticity and Neurotoxins (LaN&N), Institute of Cell Biology and Neurosci. “Prof. E. De Robertis”, School of Medicine, UBA (since 1998). Main Investigator of the National Research and Technology Council (CONICET): in Neurosci.: Neuropharmacology, Neurochemistry, Neurophysiology. Investigator 1st Category UBA (since 2001) Coordinator … Read more
Professor Isadore (Izzy) Kanfer Professor Kanfer was appointed as the first Professor of Pharmaceutics at Rhodes University in 1980 and served as Head of Pharmacy at Rhodes University and Dean of the Faculty from 1999- 2007. He obtained his BSc (Pharmacy), BSc(Honours) and PhD in Pharmaceutics at Rhodes University. He was appointed as a member of the South African Medicines Control Council (MCC) from 1999–2004, served as Chairperson of the Expert Committee (Analytical), and also chaired the MCC’s Complementary Medicines Committee. He has supervised 34 … Read more
Dr Beatrice Molac Beatrice is an independent consultant in intellectual property matters, working for small companies and the Esperanza Medicines Foundation, to contribute to the development of new therapeutic approaches. Prior to her retirement, she was Group Head of Pharma Patents, Transplantation at Novartis, where she managed a number of patent portfolios. She was an active European patent attorney for almost three decades. In addition, she was both Head of the European Qualifying Examination Committee II (Opposition Paper) and a member of the European Board … Read more
Professor Haylene Nel Professor Haylene Nel is head and owner of Tiervlei Trial Centre, a private clinical research centre. The unit is structured as a clinical trial site according to EU guidelines and has participated in over 200 international clinical trials over several therapeutic areas (phases I-IV). Haylene has a special interest in the development of natural medicinal products. She is Extra-Ordinary Associate Professor University of Western Cape Faculty of Natural Sciences, SA Herbal Science and Medicines Institute. She also presents a post graduate course … Read more
Professor Srinivas Patnala Professor Srini Patnala is currently working at KLE University’s College of Pharmacy, Belgaum, India. Previously he worked in the pharmaceutical industry for 11 years in various positions in Quality Control, Quality Assurance and related R&D departments. Srini’s main interests include quality control methods for herbal medicines. He obtained his Bachelor of Pharmacy degree from Bangalore University and Master of Pharmacy (Pharmaceutics) from Rajiv Gandhi University of Health Sciences. In 2003 he joined Rhodes University to do his Doctor of Philosophy under the … Read more
Marina Snitcofsky Veterinarian, University of Buenos Aires (UBA), graduated with honors. Diplomate in Internal Medicine of Canine and Feline, De las Américas University-UDLA. Specialized in Clinical Ethology PhD student in Neurosciences (Learning & Memory), LaN&N, IBCN, Medicine School, UBA. Director: Dr. Diana Jerusalinsky PhD Fellow at the UBA Professor of Biostatistics, Veterinary School, Del Salvador University-USAL … Read more
Victor Strugo Victor qualified as a pharmacist in pre-Zimbabwe Rhodesia, where he lectured in pharmacology before moving to South Africa in 1982. Since then he has been involved in over 500 clinical trials in two pharmaceutical companies, and currently as the CEO of Triclinium, the largest wholly South African contract research organisation which he founded in February 2000. He has written or co-authored 18 scientific papers and 26 local and international congress presentations, mostly on hypertension and haemodynamics. Victor is currently preparing the South African … Read more
Abraham van Rooyen CEO of ANB Investments (Pty) Ltd, owner of the Du Roi and Indigo group of companies. Founder of Du Roi Citrus Nursery, Du Roi Tissue culture Laboratory, Du Roi IPM (Insectary breeding insects for integrated pest management) and various new startup businesses in the innovative agriculture sector. Intimately involved in initial propagation and semi commercial production, drying and packaging of Sceletium for HGH Pharmaceuticals. Initiator of the rescue of the distressed emerging farmer projects at Mabunda and Mariveni in the Limpopo Province. … Read more
Professor Alvaro Viljoen Professor Alvaro Viljoen completed a BSc, BSc Hons. (cum laude) and MSc (cum laude) in Botany at Stellenbosch University. In 1994 he commenced with a PhD at the Rand Afrikaans University (now the University of Johannesburg) on the chemotaxonomy of the genus Aloe which was completed in 1999. In the same year he was appointed as a lecturer in Pharmaceutical Chemistry in the Department of Pharmacy, University of the Witwatersrand. In 2000 he established a Pharmacognosy research group and has since supervised … Read more
Bryan Anderson Bryan was the Managing Director, Fresh Produce for H.L. Hall & Sons between 2006 and 2011. Joining the company in 1986, he held a variety of managerial positions within the Farms division before assuming responsibility for the management of the Marketing and Fruit Procurement Department in 1997. In 1999 Bryan relocated to the UK to take up the position of Managing Director of H L Hall (International) Ltd. From August 2006, Bryan assumed responsibility for Halls’ Fresh Produce enterprise, including Farms, Exports, Value … Read more
Dr Hannes de Lange Hannes has been intimately involved in research for HGH Pharmaceuticals on Sceletium tortuosum cultivation. He has two doctorates; one awarded in agriculture (Univ. Pretoria) and another in botany (Univ. Stellenbosch). He was involved in research on citrus at the Citrus and Subtropical Fruit Research Institute in Nelspruit for nearly 20 years with the main projects on the initiation of easy peeler (naartje) cultivation in South Africa, pollination requirements, breeding and tissue culture. Highlights during this period were the establishment of a … Read more
Dr Alexander Schauss Alexander Schauss, PhD, FACN, is the Senior Research Director of Natural and Medicinal Products Research, and CEO at AIBMR Life Sciences, in Puyallup, Washington, USA. He earned his undergraduate, graduate (summa cum laude), and doctoral degrees at the University of New Mexico at Albuquerque and, California Coast University in Santa Ana. As lead scientist, Dr Schauss has been a part of the AIBMR Life Sciences team for over 30 years. He brings a wealth of experience and expertise to the wide-range of … Read more